… venous thromboembolism (VTE). Objective: These evidence-based guidelines of the American
Society of Hematology … about the use of anticoagulants in the management of VTE. These …

… Venous thromboembolism (VTE) is the third most common vascular disease. Medical
inpatients, long-term care residents, persons with minor injuries, and long-distance travelers are at …

… Anticoagulant treatment of subsegmental PE or calf vein thrombosis exposes patients to
the … the clinical importance and appropriate management of these findings are needed. …

… The management of nonpregnant patients with heparin-induced thrombocytopenia or a …
addressed by American Society of Hematology 2018 Guidelines for Venous Thromboembolism:…

… The American Society of Hematology (ASH) guideline panel recommends using … in pediatric
patients with symptomatic deep vein thrombosis (DVT) or pulmonary embolism (PE) (strong …

… assess the certainty in the evidence and formulate recommendations. Patients with cancer
are at greater risk for venous thromboembolism (VTE) compared with the general population, …

… Primary treatment refers to the minimal length of time a patient must be on therapeutic
anticoagulation to treat the initial venous thromboembolism (VTE) before consideration is given to …

… Summary of recommendations These American Society of Hematology (ASH) guidelines
are based on updated and original systematic reviews of evidence conducted by researchers …

… evidence-based guidelines of the American Society of Hematology (ASH… treatment of acute
HIT is not well established. Suggested dosing is extrapolated from venous thromboembolism …

… The preliminary results of the phase IV ADAM-VTE trial (NCT02585713) that were presented
at 60th American Society of Hematology annual meeting in 2018, suggested that apixaban …